Grace Therapeutics(GRCE.US)

BioVaxys Reports Positive Phase 1B/2 Results for MVP-S Combo in Recurrent Ovarian Cancer

BioVaxys Technology Corp. has reported positive preliminary results from its Phase 1B/2 PESCO clinical trial for the MVP-S vaccine combined with pembrolizumab and low-dose cyclophosphamide in recurrent ovarian cancer patients. The trial, led by Dr. Amit Oza, evaluated safety, dosing, and clinical efficacy, showing promising outcomes, particularly in platinum-resistant cases. Notably, one subject has maintained a complete response for three years. The results have been presented, highlighting improved efficacy over standard chemotherapy.

U.S. stock market movement update: Icon Energy surged 92.27%, Netclass Tech rose 68.73%, Polar Power increased 42.86%; TNL Mediagene fell 20.97%, Saverone 2014 dropped 20.36%

In the past hour, the overall market in the U.S. stock market has shown significant differentiation, with technology stocks and small-cap stocks performing particularly well. The surge of Icon Energy has attracted widespread attention in the market, driving the activity of related energy stocks. Meanwhile, several stocks in the pharmaceutical and technology sectors have also shown strong performance, indicating that funds seem to be seeking opportunities in these areas. In contrast, some traditional industries and large-cap stocks are under noticeable pressure, reflecting a rapid shift in fund preferences. The stock with the largest movement in the past hour, Icon Energy, surged by 92.27%, becoming the market's focal point. The influx of short-term funds has caused its stock price to rise rapidly, creating a high level of enthusiasm. The strong performance of this stock seems to have sparked investor interest in the energy sector, leading to a rise in related stocks. Strong stocks: 1. Netclass Tech: up 68.73%, as recent market attention on its technological innovations has attracted a large influx of funds. 2. Polar Power: up 42.86%, the company's layout in the renewable energy sector has sparked investor enthusiasm, with short-term funds actively participating. 3. Biodexa Pharmaceuticals: up 19.20%, optimistic expectations regarding its new drug development progress have driven the stock price up. 4. Greenland Tech: up 18.25%, benefiting significantly from the rise of green technology, with accelerated fund inflow

"Hong Kong Stocks" The Hang Seng Index fell 265 points in the first half of the day, some AI stocks and pharmaceutical stocks retreated, while power equipment stocks surged

The Hong Kong stock market fell in early trading, with the Hang Seng Index down 265 points, reporting at 26,579 points. The National Index fell 77 points, and the Hang Seng Tech Index dropped 66 points. The total turnover was HKD 132.94 billion. Smartphone manufacturers like Xiaomi lowered their shipment expectations, leading to a decline in related stock prices. Roborock's listing application was reviewed, and UBTECH ROBOTICS' stock price rose. Other tech stocks generally fell, while some AI stocks performed relatively well

Grace Therapeutics | 8-K: FY2026 Q2 Revenue: USD 0

Grace Therapeutics | 10-Q: FY2026 Q2 Revenue: USD 0